Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 376

    Early, rapid and reliable blood tests are the best way to fight dengue outbreak

    Early, rapid and reliable blood tests are the best way to fight dengue outbreak

    Ruby Khatun Khatun25 Sept 2017 9:47 AM IST
    Mumbai: Following the water deluge on August 29, Mumbaikars are now facing a deluge of Dengue cases. In the first fortnight of September itself, 1,659...
    Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries

    Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries

    Ruby Khatun Khatun25 Sept 2017 9:21 AM IST
    Basel: Novartis announced a new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current...
    Sanofi tests three-in-one antibody to treat or prevent HIV

    Sanofi tests three-in-one antibody to treat or prevent HIV

    Ruby Khatun Khatun24 Sept 2017 10:37 AM IST
    LONDON: A three-pronged man-made antibody, created by French drugmaker Sanofi and U.S. scientists, could offer a new way to treat or prevent HIV,...
    Merck KGaA, Pfizer gets EU nod for cancer drug Bavencio

    Merck KGaA, Pfizer gets EU nod for cancer drug Bavencio

    Ruby Khatun Khatun24 Sept 2017 9:57 AM IST
    FRANKFURT: European regulators on Thursday granted market approval for Merck KGaA and Pfizer’s immuno-oncology drug Bavencio to treat a rare and...
    Native American tribe moves to dismiss Allergan patent case

    Native American tribe moves to dismiss Allergan patent case

    Ruby Khatun Khatun24 Sept 2017 9:20 AM IST
    A Native American tribe holding patents for drugmaker Allergan Plc on Friday moved to dismiss a case brought by generic drug company Mylan NV...
    Rs 113 crore spent on maintenance of medical devices: J P Nadda

    Rs 113 crore spent on maintenance of medical devices: J P Nadda

    Ruby Khatun Khatun23 Sept 2017 10:42 AM IST
    New Delhi: The government has spent Rs 113 crore in 2016-17 on maintenance of 4,560 medical devices which were not functional in various public...
    Orchid Pharma gets EIR from USFDA for its Alathur facility

    Orchid Pharma gets EIR from USFDA for its Alathur facility

    Ruby Khatun Khatun23 Sept 2017 10:19 AM IST
    New Delhi: Orchid Pharma on Thursday said it has received establishment inspection report (EIR) from the US health regulator for its Alathur facility...
    FDA clears first duodenoscope with disposable distal cap

    FDA clears first duodenoscope with disposable distal cap

    Ruby Khatun Khatun23 Sept 2017 9:57 AM IST
    The U.S. Food and Drug Administration (FDA) cleared the first duodenoscope with a disposable distal cap, a new feature that will improve access for...
    Roche receives EU approval for Gazyvaro, European approval for Actemra

    Roche receives EU approval for Gazyvaro, European approval for Actemra

    Ruby Khatun Khatun23 Sept 2017 9:39 AM IST
    ZURICH: Roche said it has received European approval for its Actemra medication in giant cell arteritis (GCA), the Swiss drugmaker said on Friday.“As...
    Zydus Pharma recalls 44.8 K bottles of antidepressant in US

    Zydus Pharma recalls 44.8 K bottles of antidepressant in US

    Ruby Khatun Khatun22 Sept 2017 10:57 AM IST
    New Delhi: Cadila Healthcare's US arm, Zydus Pharmaceuticals USA Inc, is recalling 44,800 bottles of antidepressant Paroxetine tablets from the...
    Glenmark gets USFDA nod for chest pain tablets

    Glenmark gets USFDA nod for chest pain tablets

    Ruby Khatun Khatun22 Sept 2017 10:47 AM IST
    New Delhi: Glenmark Pharmaceuticals on Wednesday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets used...
    Biotech interventions to help Assam become organic hub: CM

    Biotech interventions to help Assam become organic hub: CM

    Ruby Khatun Khatun22 Sept 2017 10:19 AM IST
    Guwahati: Aiming to promote business in biotechnology and allied areas through entrepreneurship development, Assam Chief Minister Sarbananda Sonowal...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok